PATENT CLAIM ANALYSIS

Application Number: 16153376
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-03
Patent Classification: ["607", "044000"]

Abstract:
Methods and apparatus are provided for monopolar neuromodulation, e.g., via a pulsed electric field. Such monopolar neuromodulation may effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, action potential attenuation or blockade, changes in cytokine up-regulation and other conditions in target neural fibers. In some embodiments, monopolar neuromodulation is applied to neural fibers that contribute to renal function. In some embodiments, such monopolar neuromodulation is performed bilaterally.

Claim (Index 38):
The method of  claim 26  wherein the treatment site is a first treatment site and the electric field is a first electric field, and wherein the method further comprises:\n repositioning the plurality of energy delivery elements at a second treatment site within the renal blood vessel after delivering the first electric field at the first treatment site; and \n after repositioning, delivering a second electric field between the plurality of energy delivery elements and the ground pad at the second treatment site along the renal blood vessel.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 97.0
- Lexical Diversity: 1.47368
- Patent Class: 607.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14611651', '15231517', '15623428', '14548810', '15075789']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7438233802651227
- 35 USC 102 Novelty (BERT): 0.5776955954819072
- Combined Prediction Score: 0.7272106017868012
- Mean Citation Score: 552.5993139999998
- Max Citation Score: 580.3829
- Similarity Product: 402.0552938182175

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test